Research efforts have found various biomarkers of diagnostic and prognostic of RCC such as hypoxia-induced factor 1alpha (HIF1α), vascular endothelial growth factor (VEGF), and carbonic anhydrase IX (CA9), but they are not specific and sensitive enough to accurately predict the survival of RCC patients [19-21]. This evidence concerns the gene HIF1A and renal cell carcinoma.